top of page
Screenshot 2020-08-28 at 15.33.14.png




The World Health Organization (WHO) has set an ambitious goal of eliminating viral hepatitis by 20301.

At Gilead, we are working to be ahead of this target by actively supporting the efforts of governments, patient organisations, payers and healthcare providers to increase awareness, drive screening and facilitate linkage to care worldwide.


As part of our extensive commitment to this goal, we are absolutely delighted to be working with the NHS Addictions Provider Alliance and the HEP C U Later Programme across England in support of our jointly held ambition to eliminate across services by 2023.

To find out more about Gilead’s Elimination Initiatives or request Patient Support Information, Educational or Disease Awareness Materials please email:

Reference 1: (accessed August 2020)

©2020 Gilead Sciences, Inc. All rights reserved. UK-HCV-2020-08-0044
Date of preparation: August 2020

Please note, Gilead Sciences have provided sponsorship of this event but provided no input into the programme.

The views and opinions of the speakers are not necessarily those of Gilead Sciences.

bottom of page